NASDAQ · MLAB

Mesa Laboratories Inc.

$97.77 +$0.27 (+0.28%) 1D Market open
Charting by TradingView

Key Metrics

$538.68M
Market cap
80.26×
P/E · TTM
$249.13M
Revenue · TTM
$6.71M
Net income
EPS · TTM $1.25
Dividend yield 0.7%
Free cash flow $39.58M
Beta · 1Y 1.57
EBITDA · TTM $17.27M
Gross margin 63.5%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 27
    The stock moved -14.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 27
  • Mar 10
    The stock moved -16.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 10

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$538.68M
Enterprise value$579.25M
Shares outstanding5.5M
52-wk range$55.45 – $113.99
Avg volume · 20D62.6K
Net cash −$40.57M
Book value / share$34.58
IndustryIndustrial Instruments For Measurement, Display, And Control
ExchangeNASDAQ
About Mesa Laboratories Inc.
IPO dateFeb 29, 1984
Employees717

Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions.

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E80.26
P/S2.16
P/FCF13.61
EV/EBITDA33.54
EV/Sales2.33
Graham №$31.14

Profitability

Gross 63.5%
Operating 4.8%
Net 2.7%
FCF 15.9%
ROE / ROIC 3.9% · 3.0%

Financial Health

Current ratio1.72
Quick ratio1.29
Debt / equity0.36
Debt / EBITDA 3.91
Net cash −$40.57M
Working capital$44.37M

Cash Flow · TTM

Operating CF $42.83M
Capex −$3.25M
Free cash flow $39.58M
Buybacks —
Dividends paid $3.52M
Shareholder yield 0.7%

Piotroski F-Score

8 / 9
Strong fundamentals · 8 of 9 signals passing

Altman Z-Score

1.5
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

$31.14 vs $97.77
Trades 3.1× above classic defensive value — priced for growth
Fundamentals through 2025-12-31 · computed by TickerWolf from SEC filings